In particular, the Tumor Presence Signature (TPS) herein described shows an AUC of 0.788 resulting from cumulative ROC curve analysis involving CD2, CD3, CD56 and CD146, thus delineating their common involvement in LCa cancer onset and progression. This evidence concerns the gene NCAM1 and neoplasm.